Cross-platform analysis of cancer biomarkers: A Bayesian network approach to incorporating mass spectrometry and microarray data

Cancer Informatics

Volumn 3, Issue , 2007, Pages 183-202

  Deng, Xutao ^a   Geng, Huimin ^b   Ali, Hesham H ^a  

^a UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER; CHYMOTRYPSIN; TRYPSIN;

ALGORITHM; AMINO ACID SEQUENCE; ARTICLE; BAYES THEOREM; DATA ANALYSIS; DIAGNOSTIC ACCURACY; HUMAN; MASS SPECTROMETRY; MICROARRAY ANALYSIS; PREDICTION; QUALITY CONTROL; RELIABILITY; SIMULATION; BAYESIAN NETWORK; BIOINFORMATICS; CANCER DIAGNOSIS; CARBOXYLATION; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENETIC ALGORITHM; HUMAN TISSUE; MALE; MEASUREMENT PRECISION; OXIDATION; PREDICTIVE VALUE; PRINCIPAL COMPONENT ANALYSIS; PROBABILITY; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; SENSITIVITY ANALYSIS;

EID: 43049127535     PISSN: 11769351     EISSN: 11769351     Source Type: Journal    
DOI: 10.1177/117693510700300001     Document Type: Article

References (35)

1. Adkins, J.N., Varnum, S.M., Auberry, K.J., Moore, R.J., Angell, N.H., Smith, R.D., Springer, D.L. and Pounds, J.G. 2002. Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry. Mol. Cell Proteomics, 12:947-55.
2. Baggerly, K.A., Morris, J.S. and Coombes, K.R. 2004. Reproducibility of SELDI mass spectrometry patterns in serum: comparing proteomic data sets from different experiments. Bioinformatics, 20(5):777-785.
3. Bairoch, A., Apweiler, R., Wu, C.H., Barker, W.C., Boeckmann, B., Ferro, S., Gasteiger, E., Huang, H., Lopez, R., Magrane, M., Martin, M.J., Natale, D.A., O'Donovan, C., Redaschi, N. and Yeh, L.S. 2005. The Universal Protein Resource (UniProt). Nucleic Acids Res., 33:D154-D159.
4. Bellman, R. 1961, Adaptive Control Processes: A Guided Tour, Princeton University Press.
5. Bendtsen, J.D., Nielsen, H., von Heijne, G. and Brunak, S. 2004. Improved prediction of signal peptides: SignalP 3.0. J. Mol. Biol., 340:783-795.
6. Benjamini, Y. and Hochberg, Y. 1995. Controling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Statist. Soc. B., 57:289-300.
7. Conrads, T.P., Zhou, M., Petricoin, E.F.3rd, Liotta, L. and Veenstra, T.D. 2003. Cancer diagnosis using proteomic patterns. Expert Rev. Mol. Diagn., 3(4):411-420.
8. Coombes, K., Koomen, J., Baggerley, K., Morris, J. and Kobayashi, R. 2005. Understanding the Characteristics of Mass Spectrometry Data Through the Use of Simulation. Cancer Informatics, 1(1):41-52.
9. Deng, X., Geng, H. and Ali, H.H. 2005. Learning Yeast Gene Functions from Heterogeneous Sources of Data Using Hybrid Weighted Bayesian Networks. Proc. IEEE Computer Society Bioinformatics Conf., (CSB 2005); 25-34.
10. Diamandis, E.P. 2004. Mass spectrometry as a diagnostic and a cancer biomarker discovery tool. Molecular & Cellular Proteomics, 3.4: 367-378.
11. Fukuhara, H., Kuramochi, M., Nobukuni, T., Fukami, T., Saino, M., Maruyama, T., Nomura, S., Sekiya, T. and Murakami, Y. 2001. Isolation of the TSLL1 and TSLL2 genes, members of the tumor suppressor TSLC1 gene family encoding transmembrane proteins. Oncogene., 20(38):5401-5407.
12. Golub, T.R., Slonim, D.K., Tamayo, P., Huard, C., Gaasenbeek, M. et al. 1999. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science, 286:531-537.
13. Heckerman, D., Geiger, D. and Chickering, D. 1995. Learning Bayesian networks: The combination of knowledge and statistical data. Machine Learning, 20:197-243.
14. Joachims, T. 1999. Making large-Scale SVM Learning Practical. Advances in Kernel Methods-Support Vector Learning, Schölkopf, B., Burges, C. and Smola, A. (ed.), MIT-Press.
15. Liebler, D.C. 2001. Introduction to Proteomics: Tools for the New Biology. Humana Press, New Jersey.
16. Lilien, R.H., Farid, H. and Donald, B.R. 2003. Probabilistic disease classification of expression-dependent proteomic data from mass spectrometry of human serum. J. of Comp. Bio., 10(6):925-946.
17. Liu, J. and Li, M. 2005. Finding Cancer Biomarkers from Mass Spectrometry Data by Decision Lists. J. of Comp. Bio., 12(7):971-979.
18. Liu, J.J., Cutler, G., Li, W., Pan, Z., Peng, S., Hoey, T., Chen, L. and Ling, X.B. 2005. Multiclass cancer classification and biomarker discovery using GA-based algorithms. Bioinformatics, 21(11):2691-2697.
19. Lyons-Weiler. J. 2005. Standards of Excellence and Open Questions in Cancer Biomarker Research: An Informatics Perspective. Cancer Informatics, 1(1):1-7.
20. Lyons-Weiler, J., Patel, S., Becich, M.J. and Godfrey, T. 2004. Tests for finding complex patterns of differential expression in cancer: towards individualized medicine. BMC Bioinformatics, 5:110.
21. Online Mendelian Inheritance in Man, OMIM (TM). McKusick-Nathans Institute for Genetic Medicine, Johns Hopkins University (Baltimore, MD) and National Center for Biotechnology Information, National Library of Medicine (Bethesda, MD), 2000. World Wide Web URL: http://www.ncbi.nlm.nih.gov/omim/
22. Nielsen, H. and Krogh, A. 1998. Prediction of signal peptides and signal anchors by a hidden Markov model. Proc. Int. Conf. Intell. Syst. Mol. Biol., (ISMB 6); 122-130.
23. Pawitan, Y., Murthy, K.R.K., Michiels, S. and Ploner, A. 2005. Bias in the estimation of false discovery rate in microarray studies. Bioinformatics, 21(20):3865-3872.
24. Pearl, J. 1988. Probabilistic reasoning for intelligent systems. Morgan Kaufmann, San Francisco.
25. Pepe, M.S., Etzioni, R., Feng, Z., Potter, J.D., Thompson, M.L., Thornquist, M., Winget, M. and Yasui, Y. 2001. Phases of biomarker development for early detection of cancer. J. Natl. Cancer Inst., 93(14):1054-61.
26. Petricoin, E.F., Ardekani, A.M., Hitt, B.A., Levine, P.J. et al. 2002a. Use of proteomic patterns in serum to identify ovarian cancer. Lancet, 359(9306):572-577.
27. Petricoin, E.F., Ornstein, D.K., Paweletz, C.P. et al. 2002b. Serum proteomic patterns for the detection of prostate cancer. J. Natl. Cancer Inst., 94(20):1576-1578.
28. Rahuel, C., Le Van Kim, C., Mattei, M.G., Cartron, J.P. and Colin, Y. 1996. A unique gene encodes spliceforms of the B-cell adhesion molecule cell surface glycoprotein of epithelial cancer and of the Lutheran blood group glycoprotein. Blood, 88:1865-1872.
29. Richter, R., Schulz-Knappe, P., Schrader, M., Standker, L, Jurgens, M., Tammen, H. and Forssmann, W.G. 1999. Composition of the peptide fraction in human blood plasma: database of circulating human peptides. J. Chromatogr. B. Biomed. Sci. Appl., 726(1-2):25-35.
30. Singh, D., Febbo, P.G., Ross, K., Jackson, D.G., Manola, J. et al. 2002. Gene expression correlates of clinical prostate cancer behavior. Cancer Cell, 1:203-209.
31. Siuzdak, G. 2003. The Expanding Role of Mass Spectrometry in Biotechnology. MCC Press, San Diego.
32. Sorace, J.M. and Zhan, M. 2003. A data review and re-assessment of ovarian cancer serum proteomic profiling. BMC Bioinformatics, 4:24.
33. Statnikov, A., Aliferis, C.F., Tsamardinos, I., Hardin, D. and Levy, S. 2005. A comprehensive evaluation of multicategory classification methods for microarray gene expression cancer diagnosis. Bioinformatics, 21(5):631-643.
34. Wagner, M., Naik, D.N., Pothen, A., Kasukurti, S., Devineni, R.R., Adam, B.L., Semmes, O.J. and Wright, G.L. 2004. Computational protein biomarker prediction: a case study for prostate cancer. BMC Bioinformatics, 5:26.
35. Wang, C.P. and Isenhour, T.L. 1987. Time-warping algorithm applied to chromatographic peak matching gas chromatography/Fourier transform infrared/mass spectrometry. Anal. Chem., 59:649-654.